Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

In this report, we describe the kinetics characteristics of the diacylglycerol lipase-α (DGLα) located at the nuclear matrix of nuclei derived from adult cortical neurons. Thus, using high-resolution fluorescence microscopy, classical biochemical subcellular fractionation, and Western blot techniques, we demonstrate that the DGLα enzyme is located in the matrix of neuronal nuclei. Furthermore, by quantifying the 2-arachidonoylglycerol (2-AG) level by liquid chromatography and mass spectrometry when 1-stearoyl-2-arachidonoyl-sn-glycerol (SAG) was exogenously added as substrate, we describe the presence of a mechanism for 2-AG production through DGLα dependent biosynthesis with an apparent Km (Kmapp) of 180 µM and a Vmax of 1.3 pmol min−1 µg−1 protein. We also examined the presence of enzymes with hydrolytic and oxygenase activities that are able to use 2-AG as substrate, and described the localization and compartmentalization of the major 2-AG degradation enzymes, namely monoacylglycerol lipase (MGL), fatty acid amide hydrolase (FAAH), α/β-hydrolase domain 12 protein (ABHD12) and cyclooxygenase-2 (COX2). Of these, only ABHD12 exhibited the same distribution with respect to chromatin, lamin B1, SC-35 and NeuN as that described for DGLα. When 2-AG was exogenously added, we observed the production of arachidonic acid (AA), which was prevented by inhibitors (but not specific MGL or ABHD6 inhibitors) of the ABHD family. Overall, our results expand knowledge about the subcellular distribution of neuronal DGLα, and provide biochemical and morphological evidence to ensure that 2-AG is produced in the neuronal nuclear matrix. Thus, this work paves the way for proposing a working hypothesis about the role of 2-AG produced in neuronal nuclei.

[1]  C. Ledent,et al.  Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1 , 2021, Histochemistry and Cell Biology.

[2]  D. Finn,et al.  PPARs and pain , 2018, British journal of pharmacology.

[3]  L. Marnett,et al.  Aspects of Prostaglandin Glycerol Ester Biology. , 2019, Advances in experimental medicine and biology.

[4]  Cheryl A. Grice,et al.  Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. , 2018, Journal of medicinal chemistry.

[5]  M. Duchen,et al.  PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease , 2016, Free radical biology & medicine.

[6]  I. Galve-Roperh,et al.  VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease , 2016, Scientific Reports.

[7]  S. O'Sullivan,et al.  An update on PPAR activation by cannabinoids , 2016, British journal of pharmacology.

[8]  R. J. Barrio,et al.  Nuclear diacylglycerol lipase‐α in rat brain cortical neurons: evidence of 2‐arachidonoylglycerol production in concert with phospholipase C‐β activity , 2015, Journal of neurochemistry.

[9]  K. Mackie,et al.  Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS , 2014, British journal of pharmacology.

[10]  G. García del Caño,et al.  Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons. , 2014, Advances in biological regulation.

[11]  Mitsuyoshi Iino,et al.  Cytoplasmic localization of DGK&zgr; exerts a protective effect against p53-mediated cytotoxicity , 2013, Journal of Cell Science.

[12]  K. Mackie,et al.  CaMKII is a novel regulator of diacylglycerol lipase-α and striatal endocannabinoid signaling , 2013, Nature Neuroscience.

[13]  J. Laitinen,et al.  Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)[S] , 2012, Journal of Lipid Research.

[14]  I. González-Burguera,et al.  Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain , 2012, Neuroscience.

[15]  M. Zimmermann,et al.  Time-Dependent Cross Talk between Spinal Serotonin 5-HT2A Receptor and mGluR1 Subserves Spinal Hyperexcitability and Neuropathic Pain after Nerve Injury , 2012, The Journal of Neuroscience.

[16]  E. Gray,et al.  The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function , 2012, Journal of Neuroinflammation.

[17]  B. Lutz,et al.  Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  Y. Surh,et al.  15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. , 2011, Biochemical pharmacology.

[19]  K. Mackie,et al.  COX‐2 and fatty acid amide hydrolase can regulate the time course of depolarization‐induced suppression of excitation , 2011, British journal of pharmacology.

[20]  Jian Zhang,et al.  Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ , 2011, British Journal of Pharmacology.

[21]  Benjamin F. Cravatt,et al.  Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain , 2011, Journal of Pharmacology and Experimental Therapeutics.

[22]  Lei Shi,et al.  GABAergic disinhibition induced pain hypersensitivity by upregulating NMDA receptor functions in spinal dorsal horn , 2011, Neuropharmacology.

[23]  J. V. Vanden Heuvel,et al.  15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γ , 2011, Molecular Pharmacology.

[24]  Masahiko Watanabe,et al.  Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus , 2011, Proceedings of the National Academy of Sciences.

[25]  P. Kuo,et al.  Peroxisome Proliferator-activated Receptor γ Negatively Regulates IFN-β Production in Toll-like Receptor (TLR) 3- and TLR4-stimulated Macrophages by Preventing Interferon Regulatory Factor 3 Binding to the IFN-β Promoter* , 2010, The Journal of Biological Chemistry.

[26]  Agnes L. Bodor,et al.  The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors , 2010, Nature Neuroscience.

[27]  A. Aranda-Anzaldo,et al.  NeuN/Fox‐3 is an intrinsic component of the neuronal nuclear matrix , 2010, FEBS letters.

[28]  L. Parsons,et al.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls , 2010, British journal of pharmacology.

[29]  G. Muccioli Endocannabinoid biosynthesis and inactivation, from simple to complex. , 2010, Drug discovery today.

[30]  J. Long,et al.  Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling , 2009, Journal of Pharmacology and Experimental Therapeutics.

[31]  L. Parsons,et al.  Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats , 2009, Journal of neurochemistry.

[32]  K. Mackie,et al.  Cannabinoid signaling in inhibitory autaptic hippocampal neurons , 2009, Neuroscience.

[33]  P. Castillo,et al.  Endocannabinoid signaling and long-term synaptic plasticity. , 2009, Annual review of physiology.

[34]  Yongnan Li,et al.  Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats , 2008, International Journal of Developmental Neuroscience.

[35]  M. Maccarrone,et al.  FAAH and anandamide: is 2-AG really the odd one out? , 2008, Trends in pharmacological sciences.

[36]  H. Bradshaw,et al.  Prostaglandin E2 glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity , 2008, British journal of pharmacology.

[37]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[38]  M. Maftouh,et al.  CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus , 2007, The European journal of neuroscience.

[39]  S. O'Sullivan,et al.  Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors , 2007, British journal of pharmacology.

[40]  N. Sang,et al.  COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity , 2007, Journal of neurochemistry.

[41]  K. Mackie,et al.  A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization , 2007, Molecular Pharmacology.

[42]  Pedro Grandes,et al.  Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex , 2007, PloS one.

[43]  B. Cravatt,et al.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.

[44]  L. Parsons,et al.  Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration , 2007, The Journal of Neuroscience.

[45]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[46]  M. Kano,et al.  Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.

[47]  V. Marzo,et al.  Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. , 2007, Veterinary journal.

[48]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[49]  Masahiko Watanabe,et al.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  Masahiko Watanabe,et al.  Diacylglycerol kinase ζ is involved in the process of cerebral infarction , 2006 .

[51]  K. Mackie,et al.  Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.

[52]  P. Schweitzer,et al.  Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus , 2005, Neuropharmacology.

[53]  A. Poso,et al.  Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. , 2005, Chemistry & biology.

[54]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[55]  D. Piomelli,et al.  RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol , 2004, Molecular Pharmacology.

[56]  B. Alger,et al.  Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.

[57]  J. Laitinen,et al.  Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. , 2004, Biochemical pharmacology.

[58]  A. Martelli,et al.  Nuclear inositides: facts and perspectives. , 2004, Pharmacology & therapeutics.

[59]  G. Baldini,et al.  Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus , 2003 .

[60]  M. Kano,et al.  Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus , 2003, The European journal of neuroscience.

[61]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[62]  R. Irvine Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.

[63]  T. Freund,et al.  A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. , 2002, Chemistry and physics of lipids.

[64]  M. Isokawa,et al.  Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus , 2002, The Journal of Neuroscience.

[65]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Rajnish A. Gupta,et al.  15-Lipoxygenase Metabolism of 2-Arachidonylglycerol , 2002, The Journal of Biological Chemistry.

[67]  M. Kano,et al.  Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation , 2002, The European journal of neuroscience.

[68]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[69]  G. Schiavo,et al.  Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. , 2001, Journal of cell science.

[70]  B. Staels,et al.  Peroxisome proliferator-activated receptors in inflammation control. , 2001, The Journal of endocrinology.

[71]  K. Waku,et al.  Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation , 2001, Neuroscience Letters.

[72]  L. Marnett,et al.  Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[73]  L. Parsons,et al.  Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , 1999, Nature Neuroscience.

[74]  M. O’Banion,et al.  Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. , 1999, Critical reviews in neurobiology.

[75]  L. Petrocellis,et al.  Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action , 1998, Trends in Neurosciences.

[76]  S. Yamamoto,et al.  Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand , 1998, FEBS letters.

[77]  U. Hellman,et al.  cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.

[78]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[79]  D. Deutsch,et al.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. , 1997, Biochemical pharmacology.

[80]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[81]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[82]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[83]  J. Boonstra,et al.  A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. , 1992, The Journal of biological chemistry.

[84]  S. Penman,et al.  The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy , 1986, The Journal of cell biology.

[85]  D. S. Coffey,et al.  Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. , 1981, Experimental cell research.

[86]  P. Agutter,et al.  Nuclear non-chromatin proteinaceous structures: their role in the organization and function of the interphase nucleus. , 1980, Journal of cell science.

[87]  R. Thompson,et al.  STUDIES ON RNA SYNTHESIS IN TWO POPULATIONS OF NUCLEI FROM THE MAMMALIAN CEREBRAL CORTEX , 1973, Journal of neurochemistry.